Cargando…

Use of frailty assessment instruments in nephrology populations: a scoping review

BACKGROUND: Frailty is a clinical syndrome of accelerated aging associated with adverse outcomes. Frailty is prevalent among patients with chronic kidney disease but is infrequently assessed in clinical settings, due to lack of consensus regarding frailty definitions and diagnostic tools. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennard, Alice L., Rainsford, Suzanne, Glasgow, Nicholas J., Talaulikar, Girish S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360289/
https://www.ncbi.nlm.nih.gov/pubmed/37479978
http://dx.doi.org/10.1186/s12877-023-04101-y
_version_ 1785076071952023552
author Kennard, Alice L.
Rainsford, Suzanne
Glasgow, Nicholas J.
Talaulikar, Girish S.
author_facet Kennard, Alice L.
Rainsford, Suzanne
Glasgow, Nicholas J.
Talaulikar, Girish S.
author_sort Kennard, Alice L.
collection PubMed
description BACKGROUND: Frailty is a clinical syndrome of accelerated aging associated with adverse outcomes. Frailty is prevalent among patients with chronic kidney disease but is infrequently assessed in clinical settings, due to lack of consensus regarding frailty definitions and diagnostic tools. This study aimed to review the practice of frailty assessment in nephrology populations and evaluate the context and timing of frailty assessment. METHODS: The search included published reports of frailty assessment in patients with chronic kidney disease, undergoing dialysis or in receipt of a kidney transplant, published between January 2000 and November 2021. Medline, CINAHL, Embase, PsychINFO, PubMed and Cochrane Library databases were examined. A total of 164 articles were included for review. RESULTS: We found that studies were most frequently set within developed nations. Overall, 161 studies were frailty assessments conducted as part of an observational study design, and 3 within an interventional study. Studies favoured assessment of participants with chronic kidney disease (CKD) and transplant candidates. A total of 40 different frailty metrics were used. The most frequently utilised tool was the Fried frailty phenotype. Frailty prevalence varied across populations and research settings from 2.8% among participants with CKD to 82% among patients undergoing haemodialysis. Studies of frailty in conservatively managed populations were infrequent (N = 4). We verified that frailty predicts higher rates of adverse patient outcomes. There is sufficient literature to justify future meta-analyses. CONCLUSIONS: There is increasing recognition of frailty in nephrology populations and the value of assessment in informing prognostication and decision-making during transitions in care. The Fried frailty phenotype is the most frequently utilised assessment, reflecting the feasibility of incorporating objective measures of frailty and vulnerability into nephrology clinical assessment. Further research examining frailty in low and middle income countries as well as first nations people is required. Future work should focus on interventional strategies exploring frailty rehabilitation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-04101-y.
format Online
Article
Text
id pubmed-10360289
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103602892023-07-22 Use of frailty assessment instruments in nephrology populations: a scoping review Kennard, Alice L. Rainsford, Suzanne Glasgow, Nicholas J. Talaulikar, Girish S. BMC Geriatr Research BACKGROUND: Frailty is a clinical syndrome of accelerated aging associated with adverse outcomes. Frailty is prevalent among patients with chronic kidney disease but is infrequently assessed in clinical settings, due to lack of consensus regarding frailty definitions and diagnostic tools. This study aimed to review the practice of frailty assessment in nephrology populations and evaluate the context and timing of frailty assessment. METHODS: The search included published reports of frailty assessment in patients with chronic kidney disease, undergoing dialysis or in receipt of a kidney transplant, published between January 2000 and November 2021. Medline, CINAHL, Embase, PsychINFO, PubMed and Cochrane Library databases were examined. A total of 164 articles were included for review. RESULTS: We found that studies were most frequently set within developed nations. Overall, 161 studies were frailty assessments conducted as part of an observational study design, and 3 within an interventional study. Studies favoured assessment of participants with chronic kidney disease (CKD) and transplant candidates. A total of 40 different frailty metrics were used. The most frequently utilised tool was the Fried frailty phenotype. Frailty prevalence varied across populations and research settings from 2.8% among participants with CKD to 82% among patients undergoing haemodialysis. Studies of frailty in conservatively managed populations were infrequent (N = 4). We verified that frailty predicts higher rates of adverse patient outcomes. There is sufficient literature to justify future meta-analyses. CONCLUSIONS: There is increasing recognition of frailty in nephrology populations and the value of assessment in informing prognostication and decision-making during transitions in care. The Fried frailty phenotype is the most frequently utilised assessment, reflecting the feasibility of incorporating objective measures of frailty and vulnerability into nephrology clinical assessment. Further research examining frailty in low and middle income countries as well as first nations people is required. Future work should focus on interventional strategies exploring frailty rehabilitation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-04101-y. BioMed Central 2023-07-21 /pmc/articles/PMC10360289/ /pubmed/37479978 http://dx.doi.org/10.1186/s12877-023-04101-y Text en © Crown 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kennard, Alice L.
Rainsford, Suzanne
Glasgow, Nicholas J.
Talaulikar, Girish S.
Use of frailty assessment instruments in nephrology populations: a scoping review
title Use of frailty assessment instruments in nephrology populations: a scoping review
title_full Use of frailty assessment instruments in nephrology populations: a scoping review
title_fullStr Use of frailty assessment instruments in nephrology populations: a scoping review
title_full_unstemmed Use of frailty assessment instruments in nephrology populations: a scoping review
title_short Use of frailty assessment instruments in nephrology populations: a scoping review
title_sort use of frailty assessment instruments in nephrology populations: a scoping review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360289/
https://www.ncbi.nlm.nih.gov/pubmed/37479978
http://dx.doi.org/10.1186/s12877-023-04101-y
work_keys_str_mv AT kennardalicel useoffrailtyassessmentinstrumentsinnephrologypopulationsascopingreview
AT rainsfordsuzanne useoffrailtyassessmentinstrumentsinnephrologypopulationsascopingreview
AT glasgownicholasj useoffrailtyassessmentinstrumentsinnephrologypopulationsascopingreview
AT talaulikargirishs useoffrailtyassessmentinstrumentsinnephrologypopulationsascopingreview